Titel

Merkliste
1 Ergebnisse

Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethas..:

Yu Wang ; Cai-Qin Wang ; Peng Sun...
https://www.frontiersin.org/articles/10.3389/fonc.2022.796738/full. , 2022

Link: https://doi.org/10.3389/fonc.2022.796738

RT Journal
T1 <Title>Phase II Study of Gemcitabine, Peg-Asparaginase, Dexamethasone and Methotrexate Regimen for Newly Diagnosed Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Final Analysis With Long-Term Follow-Up and Rational Research for the Combination</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:319a0f8bfe754136941c20ecea6e94ba&Exemplar=1&LAN=DE
				
A1 Yu Wang
A1 Cai-Qin Wang
A1 Peng Sun
A1 Pan-Pan Liu
A1 Hang Yang
A1 Han-Yu Wang
A1 Hui-Lan Rao
A1 Su Li
A1 Wen-Qi Jiang
A1 Jia-Jia Huang
A1 Zhi-Ming Li
PB Frontiers Media S.A.
YR 2022
K1 extranodal NK/T cell lymphoma
K1 high-dose MTX and gemcitabine
K1 long-term follow-up
K1 final analysis
K1 synergistic effect
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF https://www.frontiersin.org/articles/10.3389/fonc.2022.796738/full
LK http://dx.doi.org/https://doi.org/10.3389/fonc.2022.796738
DO https://doi.org/10.3389/fonc.2022.796738
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)